- By insider
Investment company venBio Partners LLC (Current Portfolio) buys Pharvaris NV during the 3-months ended 2021Q1, according to the most recent filings of the investment company, venBio Partners LLC. As of 2021Q1, venBio Partners LLC owns 6 stocks with a total value of $318 million. These are the details of the buys and sells.
New Purchases: PHVS,
Reduced Positions: VRNA,
For the details of venBio Partners LLC's stock buys and sells,
go to https://www.gurufocus.com/guru/venbio+partners+llc/current-portfolio/portfolio
These are the top 5 holdings of venBio Partners LLC
Harmony Biosciences Holdings Inc (HRMY) - 3,504,624 shares, 36.40% of the total portfolio.
Akero Therapeutics Inc (AKRO) - 2,444,311 shares, 22.29% of the total portfolio.
Pharvaris NV (PHVS) - 2,303,310 shares, 20.26% of the total portfolio. New Position
Checkmate Pharmaceuticals Inc (CMPI) - 3,673,374 shares, 14.02% of the total portfolio.
Apellis Pharmaceuticals Inc (APLS) - 490,471 shares, 6.62% of the total portfolio.
New Purchase: Pharvaris NV (PHVS)
venBio Partners LLC initiated holding in Pharvaris NV. The purchase prices were between $25.25 and $40.11, with an estimated average price of $31.34. The stock is now traded at around $21.550000. The impact to a portfolio due to this purchase was 20.26%. The holding were 2,303,310 shares as of 2021-03-31.
Here is the complete portfolio of venBio Partners LLC. Also check out:
1. venBio Partners LLC's Undervalued Stocks
2. venBio Partners LLC's Top Growth Companies, and
3. venBio Partners LLC's High Yield stocks
4. Stocks that venBio Partners LLC keeps buyingThis article first appeared on GuruFocus.